InvestorsHub Logo
Followers 249
Posts 13655
Boards Moderated 0
Alias Born 05/19/2015

Re: 29YEARINVESTOR post# 114692

Tuesday, 10/25/2022 8:52:33 PM

Tuesday, October 25, 2022 8:52:33 PM

Post# of 118409
Just as suspected RGBP Nakedshorted over 71% again Today and real heavy for months. Yet RGBP is still up nicely from the May low LoL! Fudpucker Nakedshort and distort MM’s will always try to take it down as they Naked Short and play there games.
I would not want to be short with the news that dropped lately.
The Right News along with Big volume will catch these nakedshort MM’s off guard again! It’s just a matter of time for the next RGBP Big Fun Run IMO!
https://fintel.io/ss/us/rgbp
2022-10-25 5,511,785 + 0 = 5,511,785 / 7,670,570 = 71.86%
2022-10-24 5,767,134 + 0 = 5,767,134 / 10,689,239 = 53.95%
2022-10-21 8,533,909 + 0 = 8,533,909 / 15,642,506 = 54.56%
2022-10-20 6,750,197 + 0 = 6,750,197 / 11,694,522 = 57.72%
2022-10-19 3,334,648 + 0 = 3,334,648 / 5,221,123 = 63.87%
2022-10-18 6,781,349 + 0 = 6,781,349 / 10,012,438 = 67.73%
2022-10-17 4,487,325 + 0 = 4,487,325 / 6,079,013 = 73.82%
2022-10-13 10,667,397 + 0 = 10,667,397 / 15,545,268 = 68.62%
2022-10-12 10,119,635 + 0 = 10,119,635 / 17,509,060 = 57.80%
2022-10-07 9,632,003 + 0 = 9,632,003 / 12,789,531 = 75.31%
2022-10-06 22,921,790 + 0 = 22,921,790 / 28,244,148 = 81.16%
2022-10-05 10,232,079 + 0 = 10,232,079 / 15,567,792 = 65.73%
2022-10-04 4,276,630 + 0 = 4,276,630 / 6,517,048 = 65.62%
2022-10-03 2,669,703 + 0 = 2,669,703 / 4,544,480 = 58.75%
2022-09-30 8,110,381 + 0 = 8,110,381 / 10,990,204 = 73.80%
2022-09-27 4,491,667 + 0 = 4,491,667 / 7,743,568 = 58.01%
2022-09-23 4,557,211 + 0 = 4,557,211 / 7,516,181 = 60.63%
2022-09-22 6,327,811 + 0 = 6,327,811 / 9,220,664 = 68.63%
2022-09-21 6,232,328 + 0 = 6,232,328 / 8,439,638 = 73.85%
How much is a Cancer vaccine worth ?
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/

More DD
https://usanewshour.com/regen-biopharma-inc-files-patent-on-paradigm-shifting-rna-dna-based-approach-to-cancer-immunotherapy/98312/

https://www.prnewswire.com/news-releases/regen-biopharma-inc--begins-experiments-validating-its-proprietary-car-t-cell-therapy-301623585.html?tc=eml_cleartime